 | Up a level |
Faes, Livia; Maloca, Peter M; Hatz, Katja; Wolfensberger, Thomas J; Munk, Marion R; Sim, Dawn A; Bachmann, Lucas M; Schmid, Martin K (2023). Transforming ophthalmology in the digital century-new care models with added value for patients. Eye, 37(11), pp. 2172-2175. Nature Publishing Group 10.1038/s41433-022-02313-x
Garweg, Justus G; Blum, Claudine A; Copt, René-Pierre; Eandi, Chiara M; Hatz, Katja; Prünte, Christian F; Seelig, Eleonora; Somfai, Gábor M (2023). Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects. Ophthalmology and therapy, 12(2), pp. 639-655. Springer 10.1007/s40123-023-00647-7
Ebneter, Andreas; Michels, Stephan; Pruente, Christian; Imesch, Pascal; Eilenberger, Felix; Oesch, Susanne; Thomet-Hunziker, Isabelle P; Hatz, Katja (2020). Two-year outcomes of intravitreal aflibercept in a Swiss routine treat and extend regimen for patients with neovascular age-related macular degeneration. Scientific Reports, 10(1), p. 20256. Nature Publishing Group 10.1038/s41598-020-76354-1
Hatz, Katja; Ebneter, Andreas; Tuerksever, Cengiz; Pruente, Christian; Zinkernagel, Martin (2018). Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features. Ophthalmologica, 239(4), pp. 205-214. Karger 10.1159/000485852
Dysli, Chantal-Simone; Wolf, Sebastian; Hatz, Katja; Zinkernagel, Martin (2016). Fluorescence Lifetime Imaging in Stargardt Disease: Potential Marker for Disease Progression. Investigative ophthalmology & visual science, 57(3), pp. 832-841. Association for Research in Vision and Ophthalmology 10.1167/iovs.15-18033
